Aggregating ‘negative’ immunotherapy trials can uncover reproducible immune perturbations that are missed in single studies, reframing lack of clinical benefit as potentially informative biologic ...

When I think about design process, from the initial moments of young people working on projects, all the way to the end where ...

Aston Martin acknowledges in advance that finishing the Australian Grand Prix will be impossible. But where exactly do Honda ...

Grail and its competitors hope to advance detection of early-stage cancer through tests that can screen for many cancer types from a single blood sample. But while the potential for multi-cancer early ...

Telehealth company Hims & Hers has added Grail’s blood cancer test Galleri to its offerings as the medtech has now sent off data for a potential FDA approval. Galleri works as a simple blood test that ...

Quanterix QTRX recently announced the submission of a 510(k) premarket notification to the FDA for its multi-analyte algorithmic blood test designed to aid in the evaluation of patients with cognitive ...

BILLERICA, Mass., February 03, 2026--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, ...

MENLO PARK, Calif., Jan. 29, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced the submission of the ...

As midterm season wraps up, I couldn’t be more relieved. As a first-year student, these tests are incredibly nerve-wracking, especially for those of us, like me, who find multiple-choice questions ...